Artiva Biotherapeutics, Inc. Liquidation Value
ARTV
Other
Cash & Equivalents
$26.70M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $26.70M
Total Obligations: -$24.03M
$2.67M
Per share: $0.11
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $26.70M
AR: $67,000
Total Obligations: -$24.03M
$2.74M
Per share: $0.11
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $26.70M
AR: $67,000
Inventory: $0
Total Obligations: -$24.03M
$2.74M
Per share: $0.11
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $2.67M | $0.11 |
| Liquid Liquidation Value | $2.74M | $0.11 |
| Operating Liquidation Value | $2.74M | $0.11 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $26.70M |
| Accounts Receivable | $67,000 |
| Inventory | N/A |
| Current Liabilities | $13.09M |
| Long-term Debt | N/A |
| Op. Lease Liability | $10.90M |
| Finance Lease | $44,000 |
| Shares Outstanding | 24.4M |
Explore all 140 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $26.70M | $67,000 | N/A | $355,000 | $13.09M | N/A | $10.90M | $44,000 |
| 2025-09-30 | $25.51M | $79,000 | N/A | $848,000 | $11.12M | N/A | $11.62M | $75,000 |
| 2025-06-30 | $28.47M | $30,000 | N/A | $1.22M | $10.77M | N/A | $13.12M | $106,000 |
| 2025-03-31 | $30.40M | $234,000 | N/A | $2.04M | $12.20M | N/A | $13.86M | $137,000 |
▼ Community Notes